Clinical Trial Detail

NCT ID NCT04049539
Title Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ohio State University Comprehensive Cancer Center
Indications

acute myeloid leukemia

Therapies

CPX-351

Age Groups: adult senior

Additional content available in CKB BOOST